Free Trial
→ Wall St turns to THIS catalyst after Trump’s inauguration (From Timothy Sykes) (Ad) Free INZY Stock Alerts

Inozyme Pharma (INZY) Institutional Ownership

Inozyme Pharma logo
$1.36 0.00 (0.00%)
As of 01/17/2025 04:00 PM Eastern
Compare

Institutional Ownership Changes (13F Filings) for Inozyme Pharma (NASDAQ:INZY)

Current
Institutional Ownership
Percentage
88.30%
Number of
Institutional Buyers
(last 12 months)
27
Total
Institutional Inflows
(last 12 months)
$21.89M
Number of
Institutional Sellers
(last 12 months)
8
Total
Institutional Outflows
(last 12 months)
$6.39M
Get INZY Insider Trade Alerts

Want to know when executives and insiders are buying or selling Inozyme Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

INZY Institutional Buying and Selling by Quarter

Inozyme Pharma Major Shareholders & Ownership History

Export to Excel
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
12/26/2024JPMorgan Chase & Co.28,928$151K0.0%+31.0%0.045%
11/20/2024Virtu Financial LLC12,309$64K0.0%N/A0.019%
11/19/2024Barclays PLC76,730$401K0.0%+261.4%0.119%
11/16/2024Geode Capital Management LLC1,171,172$6.13M0.0%+1.7%1.823%
11/15/2024Barclays PLC76,730$401K0.0%+261.4%0.119%
11/15/2024Jane Street Group LLC49,460$259K0.0%+7.5%0.077%
11/15/2024Wellington Management Group LLP260,719$1.36M0.0%+11.9%0.406%
11/15/2024Sphera Funds Management LTD.1,191,140$6.23M1.0%-18.6%1.854%
11/15/2024State Street Corp1,050,420$5.49M0.0%+5.0%1.635%
11/15/2024Readystate Asset Management LP19,049$100K0.0%N/A0.030%
11/14/2024Eventide Asset Management LLC4,134,436$21.62M0.4%+5.0%6.436%
11/6/2024OneDigital Investment Advisors LLC20,000$105K0.0%+51.5%0.032%
11/5/2024GSA Capital Partners LLP35,402$185K0.0%-13.5%0.056%
10/23/2024Values First Advisors Inc.14,695$77K0.0%-13.9%0.024%
10/3/2024 SG Americas Securities LLC15,457$81K0.0%N/A0.025%
9/16/2024Cubist Systematic Strategies LLC18,891$84K0.0%N/A0.031%
8/15/2024Blue Owl Capital Holdings LP1,120,027$5.00M1.4%-11.8%1.811%
8/15/2024The Manufacturers Life Insurance Company21,427$96K0.0%+14.4%0.035%
8/15/2024Millennium Management LLC1,787,947$7.97M0.0%+154.1%2.890%
8/15/2024Deerfield Management Company L.P. Series C11,591$52K0.0%N/A0.019%
8/15/2024AQR Capital Management LLC10,807$48K0.0%-61.0%0.017%
8/15/2024Affinity Asset Advisors LLC2,856,252$12.74M1.5%+8.1%4.618%
8/14/2024Cubist Systematic Strategies LLC18,891$84K0.0%N/A0.031%
8/14/2024Samlyn Capital LLC3,350,535$14.94M0.2%+15.0%5.417%
8/9/2024Renaissance Technologies LLC187,839$838K0.0%+8.1%0.304%
8/9/2024Dimensional Fund Advisors LP380,064$1.70M0.0%+117.6%0.614%
8/8/2024Meeder Asset Management Inc.15,210$68K0.0%N/A0.025%
8/8/2024American Century Companies Inc.57,100$255K0.0%+11.0%0.092%
8/1/2024Rhumbline Advisers77,004$343K0.0%+22.0%0.124%
7/26/2024Bank of New York Mellon Corp190,896$851K0.0%+16.1%0.309%
7/19/2024Values First Advisors Inc.17,067$76K0.0%N/A0.028%
5/16/2024California State Teachers Retirement System4,799$37K0.0%-38.9%0.008%
5/16/2024Kennedy Capital Management LLC437,657$3.35M0.1%+52.2%0.708%
5/15/2024Affinity Asset Advisors LLC2,642,519$20.24M2.5%+40.1%4.272%
5/10/2024Vanguard Group Inc.2,419,020$18.53M0.0%+1.4%3.911%
5/7/2024 SG Americas Securities LLC13,926$107K0.0%-34.4%0.023%
5/3/2024GSA Capital Partners LLP131,098$1.00M0.1%-21.5%0.212%
2/20/2024Eventide Asset Management LLC3,179,837$13.55M0.2%+1.8%5.149%
2/15/2024Octagon Capital Advisors LP400,000$1.70M0.3%-69.2%0.648%
2/14/2024Superstring Capital Management LP123,944$528K0.4%N/A0.201%
Wall St turns to THIS catalyst after Trump’s inauguration (Ad)

Wall Street is already looking past Trump… To a new catalyst on the near horizon that could be even bigger than his inauguration. As soon as January 29th…

So please watch this video now before the hammer falls and it’s too late.
2/13/2024Affinity Asset Advisors LLC1,885,802$8.03M1.5%+36.7%3.053%
1/19/2024Denali Advisors LLC22,000$94K0.0%-17.6%0.036%
1/18/2024Values First Advisors Inc.13,898$59K0.0%N/A0.023%
1/12/2024 SG Americas Securities LLC21,236$90K0.0%+46.9%0.034%
11/15/2023Rock Springs Capital Management LP3,681,174$15.46M0.4%+7.4%5.960%
11/15/2023Laurion Capital Management LP677,329$2.85M0.0%+170.5%1.097%
11/15/2023Adage Capital Partners GP L.L.C.5,537,500$23.26M0.1%+30.3%8.966%
11/15/2023Affinity Asset Advisors LLC1,379,852$5.80M1.6%+83.5%2.234%
11/14/2023Eventide Asset Management LLC3,125,000$13.13M0.2%N/A5.060%
11/14/2023Schonfeld Strategic Advisors LLC311,880$1.31M0.0%+346.8%0.505%
11/14/2023Pivotal bioVenture Partners Investment Advisor LLC4,494,851$18.88M7.5%+22.8%7.278%
11/13/2023CHI Advisors LLC1,270,027$5.33M1.6%+6.3%2.056%
11/13/2023FMR LLC2,465,232$10.35M0.0%+229.2%3.992%
11/7/2023New York State Common Retirement Fund13,375$56K0.0%-21.8%0.022%
10/26/2023Strs Ohio9,900$41K0.0%N/A0.016%
10/13/2023 SG Americas Securities LLC14,452$61K0.0%N/A0.023%
9/21/2023Barclays PLC10,205$56K0.0%+62.7%0.017%
8/22/2023CHI Advisors LLC1,195,027$6.66M2.0%-11.0%1.936%
8/15/2023Sphera Funds Management LTD.1,131,967$6.31M1.0%-36.5%1.834%
8/14/2023Deep Track Capital LP1,644,021$9.16M0.4%-49.4%2.663%
8/14/2023Rock Springs Capital Management LP3,428,084$19.09M0.5%+6.6%5.553%
8/11/2023Pivotal bioVenture Partners Investment Advisor LLC3,661,518$20.40M6.7%+13.9%5.932%
8/7/2023Acadian Asset Management LLC57,468$319K0.0%N/A0.124%
8/4/2023Parallel Advisors LLC15,427$86K0.0%-22.3%0.033%
8/4/2023American International Group Inc.16,292$91K0.0%N/A0.035%
7/18/2023Denali Advisors LLC26,700$149K0.1%N/A0.061%
5/15/2023Affinity Asset Advisors LLC751,796$4.31M1.4%+50.4%1.718%
5/11/2023CHI Advisors LLC1,342,191$7.69M2.0%-39.1%3.067%
5/11/2023Knott David M Jr160,000$917K0.4%N/A0.366%
5/1/2023Virtu Financial LLC46,995$269K0.0%N/A0.107%
2/10/2023NEA Management Company LLC2,437,689$2.56M0.1%-0.3%6.035%
11/14/2022UBS Oconnor LLC165,498$444K0.0%-3.4%0.412%
8/16/2022Deerfield Management Company L.P. Series C2,696,372$12.86M0.3%+15.0%6.724%
8/15/2022Laurion Capital Management LP271,800$1.30M0.0%+2,618.0%0.678%
8/15/2022Pivotal bioVenture Partners Investment Advisor LLC2,661,154$12.69M6.4%+67.2%6.637%
8/11/2022Bioimpact Capital LLC664,980$3.17M0.9%+125.4%1.658%
8/11/2022 Overbrook Management Corp69,326$331K0.1%+314.5%0.173%
8/8/2022Walleye Capital LLC101,442$484K0.0%N/A0.253%
2/15/2022Laurion Capital Management LP13,390$91K0.0%-81.1%0.057%
2/15/2022Adage Capital Partners GP L.L.C.1,599,028$10.91M0.0%+8.9%6.757%
2/14/2022Suvretta Capital Management LLC1,013,216$6.91M0.1%+2.7%4.281%
2/11/2022Bioimpact Capital LLC302,615$2.06M0.4%-5.6%1.279%
2/8/2022Northern Trust Corp120,762$823K0.0%+4.0%0.510%
2/2/2022New York State Common Retirement Fund3,834$26K0.0%-63.3%0.016%
11/16/2021Suvretta Capital Management LLC986,400$11.43M0.2%+170.1%4.168%
11/16/2021Wellington Management Group LLP364,600$4.23M0.0%-50.0%1.541%
11/16/2021Laurion Capital Management LP70,700$819K0.0%N/A0.299%
11/16/2021BioImpact Capital LLC320,724$3.72M0.6%N/A1.355%
11/16/2021CHI Advisors LLC920,264$10.67M3.1%-0.8%3.889%
11/15/2021Deerfield Management Company L.P. Series C2,344,786$27.18M0.5%+7.6%9.910%
Wall St turns to THIS catalyst after Trump’s inauguration (Ad)

Wall Street is already looking past Trump… To a new catalyst on the near horizon that could be even bigger than his inauguration. As soon as January 29th…

So please watch this video now before the hammer falls and it’s too late.
11/15/2021Rock Springs Capital Management LP850,015$9.85M0.2%+1.2%3.592%
11/15/2021Marshall Wace LLP33,408$387K0.0%-16.9%0.141%
11/15/2021Caas Capital Management LP135,398$1.57M0.0%N/A0.572%
11/12/2021Geode Capital Management LLC198,624$2.30M0.0%+10.5%0.839%
11/8/2021Russell Investments Group Ltd.115,516$1.34M0.0%+4,518.8%0.488%
11/2/2021New York State Common Retirement Fund10,453$121K0.0%+18.8%0.044%
11/1/2021 SG Americas Securities LLC11,611$135K0.0%N/A0.049%
8/25/2021Marshall Wace LLP40,202$685K0.0%-22.4%0.170%
8/17/2021Millennium Management LLC61,313$1.05M0.0%-58.9%0.259%
8/17/2021Burrage Capital Management LLC242,517$4.13M4.1%+43.1%1.025%
(Data available from 1/1/2016 forward)

INZY Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of INZY shares?

During the previous two years, 49 institutional investors and hedge funds held shares of Inozyme Pharma. The most heavily invested institutionals were Adage Capital Partners GP L.L.C. ($23.26M), Eventide Asset Management LLC ($21.62M), Pivotal bioVenture Partners Investment Advisor LLC ($18.88M), Vanguard Group Inc. ($18.53M), Rock Springs Capital Management LP ($15.46M), Samlyn Capital LLC ($14.94M), and Affinity Asset Advisors LLC ($12.74M).Learn more on INZY's institutional investors.

What percentage of Inozyme Pharma stock is owned by institutional investors?

88.30% of Inozyme Pharma stock is owned by institutional investors. Learn more on INZY's institutional investor holdings.

Which institutional investors have been buying Inozyme Pharma stock?

Of the 39 institutional investors that purchased Inozyme Pharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Eventide Asset Management LLC ($3.38M), Affinity Asset Advisors LLC ($2.36M), FMR LLC ($1.72M), Adage Capital Partners GP L.L.C. ($1.29M), Pivotal bioVenture Partners Investment Advisor LLC ($1.28M), Millennium Management LLC ($1.08M), and Rock Springs Capital Management LP ($466.27K).

How much institutional buying is happening at Inozyme Pharma?

Institutional investors have bought a total of 14,038,656 shares in the last 24 months. This purchase volume represents approximately $65.04M in transactions.

Which Inozyme Pharma major shareholders have been selling company stock?

Of the 14 institutional investors that sold Inozyme Pharma stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Deep Track Capital LP ($1.61M), CHI Advisors LLC ($1.01M), Sphera Funds Management LTD. ($921.48K), Octagon Capital Advisors LP ($900K), Blue Owl Capital Holdings LP ($150K), GSA Capital Partners LLP ($41.44K), and AQR Capital Management LLC ($16.91K).

How much institutional selling is happening at Inozyme Pharma?

Institutional investors have sold a total of 4,677,943 shares in the last 24 months. This volume of shares sold represents approximately $24.79M in transactions.


Related Companies

This page (NASDAQ:INZY) was last updated on 1/20/2025 by MarketBeat.com Staff
From Our Partners
Bill Gates’ is about to mint millionaires (again) with Stargate.
This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...
Brownstone Research | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
January 29th - the next big trading catalyst to watch
Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...
Timothy Sykes | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Trump secret stock already up 339%
In this video, you’ll also get nine other Trump-connected investments… All of which we believe could have a...
Porter & Company | Sponsored
liberals FOOLED by Elon’s shocking surprise
Elon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...
StocksToTrade | Sponsored
Why Buffett, Griffin and 100 members of Congress are Piling into this One Investment
This isn't just another investment. It might be the last retirement stock you'll ever need. But this win...
Behind the Markets | Sponsored
Stunning Trump Exec Order Leaked
Most people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...
Banyan Hill Publishing | Sponsored